No Detail Found!

Clinico-haematological profile and post- induction remission status of newly diagnosed paediatric acute lymphoblastic leukaemia patients with ETV6::RUNXI1 gene rearrangement

Author(s)
Fauzia Khan Armed Forces Institute of Pathology, Rawalpindi. Pakistan
Hamid Saeed Malik Armed Forces Institute of Pathology, Rawalpindi. Pakistan
Manzar Bozdar Armed Forces Institute of Pathology, Rawalpindi. Pakistan
Rafia Mahmood Armed Forces Institute of Pathology, Rawalpindi. Pakistan
Ayesha Khurshhed Armed Forces Institute of Pathology, Rawalpindi. Pakistan
Muhammad Umar Armed Forces Institute of Pathology, Rawalpindi. Pakistan
Abstract
Objectives: To determine the frequency of ETV6:RUNX1 gene rearrangement in paediatric acute lymphoblastic leukaemia in Pakistan and to determine the clinico-haematological profile and post induction remission status of newly diagnosed paediatric acute lymphoblastic leukaemia and compare them across gender and based on ETV6::RUNX1 gene rearrangement positivity. Methodology: This descriptive cross-sectional study was conducted at Department of Haematology, Armed Forces Institute of Pathology, Rawalpindi, Oct 2021 to Aug 2023. The study sample was composed of 229 cases of paediatric acute B-cell lymphoblastic leukaemia. Patients who had B-ALL occurring as a second malignancy, Down's syndrome, those who had received chemotherapy or corticosteroids were excluded. Patients ETV6:RUNX1 gene rearrangement status was determined by PCR. All patients underwent induction with the UK ALL 2019 protocol. Bone marrow aspiration and trephine was conducted on Day+29 of induction to assess remission and MRD status. Results: Our study sample had a median age of 3.0 (IQR: 4.0) years, 136 (59.4%) were male. ETV6::RUNX1 gene rearrangement was seen in 36 (15.7%) cases. There were no statistical differences with regards to clinico-haematological profile at presentation and outcomes between genders and among patients with and without ETV6:RUNX1 gene rearrangement, except for MRD which had a higher frequency of being negative in the former, (p=0.023). Conclusion: ETV6::RUNX1 rearrangement is associated with a higher frequency of negative MRD postinduction.
Publication Details
Page(s) 68-73
DOI DOI not available
Published Journal: Journal of Haematology and Stem Cell Research, Volume: 3, Issue: 2, Year: 2023

Request the full text from PASTIC

Keywords
Post-induction remission status, ETV6:RUNX1 Gene Rearrangement, Paediatric Acute Lymphoblastic Leukaemia, Clinico-Haematological Profile
0

Citations

0

Downloads

46

Views